Study of Adrenal Gland Tumors

CompletedOBSERVATIONAL

Enrollment

690

Participants

Timeline

Start Date

July 1, 2002

Conditions

Adrenal Gland Neoplasm

Trial Locations (1)

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00005927 - Study of Adrenal Gland Tumors | Biotech Hunter | Biotech Hunter